» Articles » PMID: 32899442

Pathways of Gastric Carcinogenesis, Virulence and Interactions with Antioxidant Systems, Vitamin C and Phytochemicals

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2020 Sep 9
PMID 32899442
Citations 47
Authors
Affiliations
Soon will be listed here.
Abstract

is a class one carcinogen which causes chronic atrophic gastritis, gastric intestinal metaplasia, dysplasia and adenocarcinoma. The mechanisms by which interacts with other risk and protective factors, particularly vitamin C in gastric carcinogenesis are complex. Gastric carcinogenesis includes metabolic, environmental, epigenetic, genomic, infective, inflammatory and oncogenic pathways. The molecular classification of gastric cancer subtypes has revolutionized the understanding of gastric carcinogenesis. This includes the tumour microenvironment, germline mutations, and the role of bacteria, virus and epigenetics in somatic mutations. There is evidence that ascorbic acid, phytochemicals and endogenous antioxidant systems can modify the risk of gastric cancer. Gastric juice ascorbate levels depend on dietary intake of ascorbic acid but can also be decreased by infection, CagA secretion, tobacco smoking, achlorhydria and chronic atrophic gastritis. Ascorbic acid may be protective against gastric cancer by its antioxidant effect in gastric cytoprotection, regenerating active vitamin E and glutathione, inhibiting endogenous N-nitrosation, reducing toxic effects of ingested nitrosodimethylamines and heterocyclic amines, and preventing infection. The effectiveness of such cytoprotection is related to strain virulence, particularly CagA expression. The role of vitamin C in epigenetic reprogramming in gastric cancer is still evolving. Other factors in conjunction with vitamin C also play a role in gastric carcinogenesis. Eradication of may lead to recovery of vitamin C secretion by gastric epithelium and enable regression of premalignant gastric lesions, thereby interrupting the Correa cascade of gastric carcinogenesis.

Citing Articles

Enhancement of host defense against infection through modulation of the gastrointestinal microenvironment by Lp05.

Dong Y, Han M, Qi Y, Wu Y, Zhou Z, Jiang D Front Immunol. 2025; 15:1469885.

PMID: 39896799 PMC: 11782045. DOI: 10.3389/fimmu.2024.1469885.


Pivotal role of virulence genes in pathogenicity and vaccine development.

Elbehiry A, Marzouk E, Abalkhail A, Sindi W, Alzahrani Y, Alhifani S Front Med (Lausanne). 2025; 11():1523991.

PMID: 39850097 PMC: 11756510. DOI: 10.3389/fmed.2024.1523991.


Exploring the link between dietary patterns and gastric adenocarcinoma in Brazil: a mediation analysis.

Silva A, Alicandro G, Guandalini V, da Fonseca Grili P, Assumpcao P, Barbosa M BMC Med. 2024; 22(1):562.

PMID: 39609810 PMC: 11603788. DOI: 10.1186/s12916-024-03785-2.


Discovery of Cinnamic Acid Derivatives as Potent Anti- Agents.

Li Y, Zhao K, Wu Z, Zheng Y, Yu J, Wu S Molecules. 2024; 29(19).

PMID: 39407478 PMC: 11477721. DOI: 10.3390/molecules29194548.


Aspirin but not statins is inversely related to gastric cancer with a duration-risk effect: Results from the Stomach Cancer Pooling Project Consortium.

Pastorino R, Pires Marafon D, Sassano M, Hoxhaj I, Pelucchi C, Liao L Cancer. 2024; 130(24):4276-4286.

PMID: 39154222 PMC: 11585341. DOI: 10.1002/cncr.35510.


References
1.
Valavanidis A, Vlachogianni T, Fiotakis K . Tobacco smoke: involvement of reactive oxygen species and stable free radicals in mechanisms of oxidative damage, carcinogenesis and synergistic effects with other respirable particles. Int J Environ Res Public Health. 2009; 6(2):445-62. PMC: 2672368. DOI: 10.3390/ijerph6020445. View

2.
Uemura N, Okamoto S, Yamamoto S, Matsumura N, Yamaguchi S, Yamakido M . Helicobacter pylori infection and the development of gastric cancer. N Engl J Med. 2001; 345(11):784-9. DOI: 10.1056/NEJMoa001999. View

3.
Starczak M, Zarakowska E, Modrzejewska M, Dziaman T, Szpila A, Linowiecka K . In vivo evidence of ascorbate involvement in the generation of epigenetic DNA modifications in leukocytes from patients with colorectal carcinoma, benign adenoma and inflammatory bowel disease. J Transl Med. 2018; 16(1):204. PMC: 6053776. DOI: 10.1186/s12967-018-1581-9. View

4.
Lee D, Jung D, Yu S, Lee Y, Choi B, Lee Y . Regulation of SIRT3 signal related metabolic reprogramming in gastric cancer by oncoprotein CagA. Oncotarget. 2017; 8(45):78365-78378. PMC: 5667968. DOI: 10.18632/oncotarget.18695. View

5.
Gonzalez C, Megraud F, Buissonniere A, Lujan Barroso L, Agudo A, Duell E . Helicobacter pylori infection assessed by ELISA and by immunoblot and noncardia gastric cancer risk in a prospective study: the Eurgast-EPIC project. Ann Oncol. 2011; 23(5):1320-1324. DOI: 10.1093/annonc/mdr384. View